Shalini L Kulasingam

Learn More
BACKGROUND We assessed the cost-effectiveness of adding a quadrivalent (6/11/16/18) human papillomavirus (HPV) vaccine to the current screening programme in the UK compared to screening alone. METHODS A Markov model of the natural history of HPV infection incorporating screening and vaccination was developed. A vaccine that prevents 98% of HPV 6, 11, 16(More)
Although cigarette smoking has been identified as a cofactor for cervical neoplasia, it is not clear whether smoking exerts an early or late effect on the evolution of human papillomavirus (HPV)-related lesions. A case-control study of Washington State women who presented for routine gynecologic care from 1997 to 2001 was conducted. All women underwent(More)
ii This document was written with support from the Effective Health Care Program at the Agency for Healthcare Research and Quality (AHRQ). Its findings and conclusions are those of the authors, who are responsible for its contents; the findings and conclusions do not necessarily represent the views of AHRQ. Therefore, no statement in this document should be(More)
OBJECTIVES To assess the evidence that the use of genomic tests for ovarian cancer screening, diagnosis, and treatment leads to improved outcomes. DATA SOURCES PubMed and reference lists of recent reviews. REVIEW METHODS We evaluated tests for: (a) single gene products; (b) genetic variations affecting risk of ovarian cancer; (c) gene expression; and(More)
Limited by what is reported in the literature, most systematic reviews of medical tests focus on "test accuracy" (or better, test performance), rather than on the impact of testing on patient outcomes. The link between testing, test results and patient outcomes is typically complex: even when testing has high accuracy, there is no guarantee that physicians(More)
Limited by what is reported in the literature, most systematic reviews of medical tests focus on " test accuracy " (or better, test performance) rather than on the impact of testing on patient outcomes. The links between testing, test results, and patient outcomes are typically complex: even when testing has high accuracy, there is no guarantee that(More)
BACKGROUND Recently published results from a large randomized trial (Canadian Cervical Cancer Screening Trial study group) suggest that human papillomavirus testing followed by Pap smear-based triage for human papillomavirus positive women may be an effective way to screen women for cervical cancer. We determined the potential cost-effectiveness of(More)
BACKGROUND Federally funded surveys of human papillomavirus (HPV) vaccine uptake are important for pinpointing geographically based health disparities. Although national and state level data are available, local (ie, county and postal code level) data are not due to small sample sizes, confidentiality concerns, and cost. Local level HPV vaccine uptake data(More)
OBJECTIVES To identify factors associated with human papillomavirus (HPV) vaccination and to determine the geographic distribution of vaccine uptake while accounting for spatial autocorrelation. DESIGN This study is cross-sectional in design using data collected via the Internet from the Survey of Minnesotans About Screening and HPV study. SETTING AND(More)
  • 1